Update Reimbursement Scheme Forxiga® - HFpEF
TerugBetaalRegeling Forxiga® (dapagliflozin) 10 mg for patients with symptomatic chronic heart failure with a LVEF ≥ 40% (HFmrEF &...
Reimbursement Scheme Signifor®
The health insurer does not fully reimburse Signifor® 20mg. The producer of this medicine has therefore asked TBR Nederland to...
Update TerugBetaalRegeling Veltassa®, patiromer 8.4g
From May 1, 2023, the use of Veltassa® 8.4g will be fully reimbursed by the health insurer. For this reason the Reimbursement...
Update Reimbursement Scheme Jardiance®
From April 1, 2023, the use of Jardiance® (empagliflozin) in patients with chronic heart failure regardless of ejection fraction...
Update Reimbursement Fludrace®
The existing TBR for Fludrace® 62.50 micrograms has been expanded with the strength 31.25 micrograms. Because the health insurer...
Select your medicine
Check your medicine expenses
Quickly check the maximum contribution you have to pay for your medicine